1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SMAD9 CTRPv2 pan-cancer AAC 0.21 6e-07
mRNA ATP2B3 CTRPv2 pan-cancer AAC 0.18 6e-07
mRNA MICAL1 CTRPv2 pan-cancer AAC 0.19 6e-07
mRNA IRAK3 CTRPv2 pan-cancer AAC 0.18 7e-07
mRNA LAMP5 CTRPv2 pan-cancer AAC 0.17 7e-07
mRNA SYP CTRPv2 pan-cancer AAC 0.18 7e-07
mRNA SMIM17 CTRPv2 pan-cancer AAC 0.18 7e-07
mRNA RCOR3 CTRPv2 pan-cancer AAC 0.18 7e-07
mRNA ZNF8 CTRPv2 pan-cancer AAC 0.19 7e-07
mRNA CLTCL1 CTRPv2 pan-cancer AAC 0.17 8e-07
Download CSV